FASLG polymorphism is associated with cancer risk.
Liu Y, Wen QJ, Yin Y, Lu XT, Pu SH, Tian HP, Lou YF, Tang YN, Jiang X, Lu GS, Zhang J.
Liu Y, et al. Among authors: yin y.
Eur J Cancer. 2009 Sep;45(14):2574-8. doi: 10.1016/j.ejca.2009.04.001. Epub 2009 May 4.
Eur J Cancer. 2009.
PMID: 19403301
Review.